Comparing Simvastatin Monotherapy V/S Simvastatin-Ezetimibe Combination Therapy for the Treatment of Hyperlipidemia: A Meta-Analysis and Review-Reference-Cited by-同舟云学术

Comparing Simvastatin Monotherapy V/S Simvastatin-Ezetimibe Combination Therapy for the Treatment of Hyperlipidemia: A Meta-Analysis and Review

Published:2022-11-02 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Chauhan Dhruva,Memon Farzana,Patwardhan Vaibhav,Kotwani Priya,Shah Parth,Samala Venkata Vikramaditya

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference39 articles.

1. Estimating deaths from cardiovascular disease: a review of global methodologies of mortality measurement;Pagidipati NJ;Circulation,2013

2. Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease;Navar-Boggan AM;Circulation,2015

3. Heart Disease and Stroke Statistics-2020 Update: a report from the American Heart Association;Virani SS;Circulation,2020

4. Hypertriglyceridemia Management According to the 2018 AHA/ACC Guideline. American College of Cardiology. (2022). Accessed. September 3, 2022: https://www.acc.org/latest-in-cardiology/articles/2019/01/11/07/39/hypertriglyceridemia-management-according-to-the-2....

5. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Grundy SM;Circulation,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are We Using Ezetimibe As Much As We Should?;Biomarker Insights;2024-01

2. The Development of Dyslipidemia in Chronic Kidney Disease and Associated Cardiovascular Damage, and the Protective Effects of Curcuminoids;Foods;2023-02-22